Skip to main content
NCBI home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1985 Aug;143(2):202–206.

Blood and Plasma Substitutes—Plasma Expansion and Oxygen Transport Properties

Kenneth Waxman 1,2, G Robert Mason 1,2, Kevin K Tremper 1,2
PMCID: PMC1306272  PMID: 2412350

Abstract

Because of the risks and costs of blood and blood product infusion, developing blood and plasma substitutes is of significance. Two currently utilized substances, dextran and hydroxyethyl starch, are effective colloid plasma expanders. The dextrans have properties that improve microcirculatory blood flow but are associated with several possible adverse effects. Hydroxyethyl starch is a well-tolerated agent that has efficacy similar to albumin but at a lower cost. Two newer substances, perfluorocarbons and stroma-free hemoglobin, are being developed to improve oxygen transport as well as plasma expansion.

Full text

PDF
202

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amundson B., Jennische E., Haljamäe H. Skeletal muscle microcirculatory and cellular metabolic effects of whole blood, Ringer's acetate, and dextran 70 infusions in hemorrhagic shock. Circ Shock. 1980;7(2):111–120. [PubMed] [Google Scholar]
  2. Atik M. The uses of dextran in surgery: a current evaluation. Surgery. 1969 Mar;65(3):548–562. [PubMed] [Google Scholar]
  3. BLOOM W. L., HARMER D. S., BRYANT M. F., BREWER S. S. COATING OF VASCULAR SURFACES AND CELLS. A NEW CONCEPT IN PREVENTION OF INTRAVASCULAR THROMBOSIS. Proc Soc Exp Biol Med. 1964 Feb;115:384–386. doi: 10.3181/00379727-115-28920. [DOI] [PubMed] [Google Scholar]
  4. Birndorf N. I., Lopas H. Effects of red cell stroma-free hemoglobin solution on renal function in monkeys. J Appl Physiol. 1970 Nov;29(5):573–578. doi: 10.1152/jappl.1970.29.5.573. [DOI] [PubMed] [Google Scholar]
  5. Biro G. P. Comparison of acute cardiovascular effects and oxygen-supply following haemodilution with dextran, stroma-free haemoglobin solution and fluorocarbon suspension. Cardiovasc Res. 1982 Apr;16(4):194–204. doi: 10.1093/cvr/16.4.194. [DOI] [PubMed] [Google Scholar]
  6. Bonhard K. Acute oxygen supply by infusion of hemoglobin solutions. Fed Proc. 1975 May;34(6):1466–1467. [PubMed] [Google Scholar]
  7. Clark L. C., Jr, Clark E. W., Moore R. E., Kinnett D. G., Inscho E. I., Jr Room temperature-stable biocompatible fluorocarbon emulsions. Prog Clin Biol Res. 1983;122:169–180. [PubMed] [Google Scholar]
  8. Clark L. C., Jr, Gollan F. Survival of mammals breathing organic liquids equilibrated with oxygen at atmospheric pressure. Science. 1966 Jun 24;152(3730):1755–1756. doi: 10.1126/science.152.3730.1755. [DOI] [PubMed] [Google Scholar]
  9. Cochin A., Das Gupta T. K., De Woskin R., Moss G. S. Immunogenic properties of stroma vs stroma-free hemoglobin solution. Surg Forum. 1972;23(0):19–21. [PubMed] [Google Scholar]
  10. Dawidson I., Eriksson B. Statistical evaluation of plasma substitutes based on 10 variables. Crit Care Med. 1982 Oct;10(10):653–657. doi: 10.1097/00003246-198210000-00007. [DOI] [PubMed] [Google Scholar]
  11. De Venuto F., Moores W. Y., Zegna A. I., Zuck T. F. Total and partial blood exchange in the rat with hemoglobin prepared by crystallization. Transfusion. 1977 Nov-Dec;17(6):555–556. doi: 10.1046/j.1537-2995.1977.17678075650.x. [DOI] [PubMed] [Google Scholar]
  12. De Venuto F., Zuck T. F., Zegna A. I., Moores W. Y. Characteristics of stroma-free hemoglobin prepared by crystallization. J Lab Clin Med. 1977 Mar;89(3):509–516. [PubMed] [Google Scholar]
  13. DeVenuto F., Friedman H. I., Neville J. R., Peck C. C. Appraisal of hemoglobin solution as a blood substitute. Surg Gynecol Obstet. 1979 Sep;149(3):417–436. [PubMed] [Google Scholar]
  14. DeVenuto F. Hemoglobin solutions as oxygen-delivering resuscitation fluids. Crit Care Med. 1982 Apr;10(4):238–245. doi: 10.1097/00003246-198204000-00002. [DOI] [PubMed] [Google Scholar]
  15. DeVenuto F. Stability of hemoglobin solution during extended storage. J Lab Clin Med. 1978 Dec;92(6):946–952. [PubMed] [Google Scholar]
  16. Djordjevich L., Miller I. F. Synthetic erythrocytes from lipid encapsulated hemoglobin. Exp Hematol. 1980 May;8(5):584–592. [PubMed] [Google Scholar]
  17. EWALD R. A., EICHELBERGER J. W., Jr, YOUNG A. A., WEISS H. J., CROSBY W. H. THE EFFECT OF DEXTRAN ON PLATELET FACTOR 3 ACTIVITY: IN VITRO AND IN VIVO STUDIES. Transfusion. 1965 Mar-Apr;5:109–119. doi: 10.1111/j.1537-2995.1965.tb01146.x. [DOI] [PubMed] [Google Scholar]
  18. Feest T. G. Low molecular weight dextran: a continuing cause of acute renal failure. Br Med J. 1976 Nov 27;2(6047):1300–1300. doi: 10.1136/bmj.2.6047.1300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Friedman H. I., De Venuto F., Schwartz B. D., Nemeth T. J. In vivo evaluation of pyridoxalated-polymerized hemoglobin solution. Surg Gynecol Obstet. 1984 Nov;159(5):429–435. [PubMed] [Google Scholar]
  20. Friedman H. I., DeVenuto F., Lollini L., Mellick P., Zuck T. F. Morphologic effects following massive exchange transfusions with a stroma-free hemoglobin solution. I. Liver. Lab Invest. 1978 Aug;39(2):167–177. [PubMed] [Google Scholar]
  21. Furhoff A. K. Anaphylactoid reaction to dextran---a report of 133 cases. Acta Anaesthesiol Scand. 1977;21(3):161–167. doi: 10.1111/j.1399-6576.1977.tb01205.x. [DOI] [PubMed] [Google Scholar]
  22. GELIN L. E., SOLVELL L., ZEDERFELDT B. The plasma volume expanding effect of low viscous dextran and Macrodex. Acta Chir Scand. 1961 Nov;122:309–323. [PubMed] [Google Scholar]
  23. Geyer R. P. Fluorocarbon-polyol artificial blood substitutes. N Engl J Med. 1973 Nov 15;289(20):1077–1082. doi: 10.1056/NEJM197311152892008. [DOI] [PubMed] [Google Scholar]
  24. Gould S. A., Rosen A., Sehgal L., Noud G., Sehgal H., DeWoskin R., Levine H., Kerstein M., Rice C., Moss G. S. The effect of altered hemoglobin-oxygen affinity on oxygen transport by hemoglobin solution. J Surg Res. 1980 Mar;28(3):246–251. doi: 10.1016/0022-4804(80)90123-7. [DOI] [PubMed] [Google Scholar]
  25. Haupt M. T., Rackow E. C. Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions. Crit Care Med. 1982 Mar;10(3):159–162. doi: 10.1097/00003246-198203000-00004. [DOI] [PubMed] [Google Scholar]
  26. Inoue S., Nagai Y., Ueno K., Ota T., Koike S. [Effect of hydroxyethyl starch (HES) on blood coagulation in general anesthesia]. Masui. 1972 Jan;21(1):27–31. [PubMed] [Google Scholar]
  27. Kaplan H. R., Murthy V. S. Hemoglobin solution: a potential oxygen transporting plasma volume expander. Fed Proc. 1975 May;34(6):1461–1465. [PubMed] [Google Scholar]
  28. Karlson K. E., Garzon A. A., Shaftan G. W., Chu C. J. Increased blood loss associated with administration of certain plasma expanders: dextran 75, dextran 40, and hydroxyethyl starch. Surgery. 1967 Oct;62(4):670–678. [PubMed] [Google Scholar]
  29. Köhler H., Kirch W., Horstmann H. J. Die Bildung hochmolekularer Komplexe aus Serumamylase und kolloidalen Plasmaersatzmitteln. Anaesthesist. 1977 Nov;26(11):623–627. [PubMed] [Google Scholar]
  30. LONG D. M., Jr The status of plasma expanders in open heart surgery. Dis Chest. 1962 May;41:578–581. doi: 10.1378/chest.41.5.578. [DOI] [PubMed] [Google Scholar]
  31. Lamke L. O., Liljedahl S. O. Plasma volume changes after infusion of various plasma expanders. Resuscitation. 1976;5(2):93–102. doi: 10.1016/0300-9572(76)90029-0. [DOI] [PubMed] [Google Scholar]
  32. Lazrove S., Waxman K., Shippy C., Shoemaker W. C. Hemodynamic, blood volume, and oxygen transport responses to albumin and hydroxyethyl starch infusions in critically ill postoperative patients. Crit Care Med. 1980 May;8(5):302–306. doi: 10.1097/00003246-198005000-00007. [DOI] [PubMed] [Google Scholar]
  33. MOORE F. D. TRIS BUFFER, MANNITOL AND LOW VISCOUS DEXTRAN: THREE NEW SOLUTIONS FOR OLD PROBLEMS. Anesth Analg. 1964 May-Jun;43:256–268. [PubMed] [Google Scholar]
  34. Mailloux L., Swartz C. D., Capizzi R., Kim K. E., Onesti G., Ramirez O., Brest A. N. Acute renal failure after administration of low-molecular weight dextran. N Engl J Med. 1967 Nov 23;277(21):1113–1118. doi: 10.1056/NEJM196711232772103. [DOI] [PubMed] [Google Scholar]
  35. Metcalf W., Papadopoulos A., Tufaro R., Barth A. A clinical physiologic study of hydroxyethyl starch. Surg Gynecol Obstet. 1970 Aug;131(2):255–267. [PubMed] [Google Scholar]
  36. Mitsuno T., Ohyanagi H., Naito R. Clinical studies of a perfluorochemical whole blood substitute (Fluosol-DA) Summary of 186 cases. Ann Surg. 1982 Jan;195(1):60–69. doi: 10.1097/00000658-198201001-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Moggio R. A., Rha C. C., Somberg E. D., Praeger P. I., Pooley R. W., Reed G. E. Hemodynamic comparison of albumin and hydroxyethyl starch in postoperative cardiac surgery patients. Crit Care Med. 1983 Dec;11(12):943–945. doi: 10.1097/00003246-198312000-00009. [DOI] [PubMed] [Google Scholar]
  38. Moss G. S., DeWoskin R., Rosen A. L., Levine H., Palani C. K. Transport of oxygen and carbon dioxide by hemoglobin-saline solution in the red cell-free primate. Surg Gynecol Obstet. 1976 Mar;142(3):357–362. [PubMed] [Google Scholar]
  39. Murray S., Dewar P. J. Low molecular weight dextran and matching by enzyme technics. Transfusion. 1971 Nov-Dec;11(6):378–381. doi: 10.1111/j.1537-2995.1971.tb04432.x. [DOI] [PubMed] [Google Scholar]
  40. Palanzo D. A., Parr G. V., Bull A. P., Williams D. R., O'Neill M. J., Waldhausen J. A. Hetastarch as a prime for cardiopulmonary bypass. Ann Thorac Surg. 1982 Dec;34(6):680–683. doi: 10.1016/s0003-4975(10)60908-3. [DOI] [PubMed] [Google Scholar]
  41. Peskin G. W., O'Brien K., Rabiner S. F. Stroma-free hemoglobin solution: the "ideal" blood substitute? Surgery. 1969 Jul;66(1):185–193. [PubMed] [Google Scholar]
  42. Police A. M., Waxman K., Tominaga G. Pulmonary complications after Fluosol administration to patients with life-threatening blood loss. Crit Care Med. 1985 Feb;13(2):96–98. doi: 10.1097/00003246-198502000-00008. [DOI] [PubMed] [Google Scholar]
  43. Puri V. K., Paidipaty B., White L. Hydroxyethyl starch for resuscitation of patients with hypovolemia and shock. Crit Care Med. 1981 Dec;9(12):833–837. doi: 10.1097/00003246-198112000-00006. [DOI] [PubMed] [Google Scholar]
  44. Rabiner S. F., Helbert J. R., Lopas H., Friedman L. H. Evaluation of a stroma-free hemoglobin solution for use as a plasma expander. J Exp Med. 1967 Dec 1;126(6):1127–1142. doi: 10.1084/jem.126.6.1127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Rabiner S. F. Hemoglobin solution as a plasma expander. Fed Proc. 1975 May;34(6):1454–1457. [PubMed] [Google Scholar]
  46. Ring J., Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet. 1977 Feb 26;1(8009):466–469. doi: 10.1016/s0140-6736(77)91953-5. [DOI] [PubMed] [Google Scholar]
  47. Shoemaker W. C. Comparison of the relative effectiveness of whole blood transfusions and various types of fluid therapy in resuscitation. Crit Care Med. 1976 Mar-Apr;4(2):71–78. doi: 10.1097/00003246-197603000-00006. [DOI] [PubMed] [Google Scholar]
  48. Solanke T. F. Clinical trial of 6 per cent hydroxyethyl starch (a new plasma expander). Br Med J. 1968 Sep 28;3(5621):783–785. doi: 10.1136/bmj.3.5621.783. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Solanke T. F., Khwaja M. S., Madojemu E. I. Plasma volume studies with four different plasma volume expanders. J Surg Res. 1971 Mar;11(3):140–143. doi: 10.1016/0022-4804(71)90038-2. [DOI] [PubMed] [Google Scholar]
  50. Tremper K. K., Friedman A. E., Levine E. M., Lapin R., Camarillo D. The preoperative treatment of severely anemic patients with a perfluorochemical oxygen-transport fluid, Fluosol-DA. N Engl J Med. 1982 Jul 29;307(5):277–283. doi: 10.1056/NEJM198207293070503. [DOI] [PubMed] [Google Scholar]
  51. Vercellotti G. M., Hammerschmidt D. E., Craddock P. R., Jacob H. S. Activation of plasma complement by perfluorocarbon artificial blood: probable mechanism of adverse pulmonary reactions in treated patients and rationale for corticosteroids prophylaxis. Blood. 1982 Jun;59(6):1299–1304. [PubMed] [Google Scholar]
  52. Waxman K., Cheung C. K., Mason G. R. Hypotensive reaction after infusion of a perfluorochemical emulsion. Crit Care Med. 1984 Jul;12(7):609–610. doi: 10.1097/00003246-198407000-00016. [DOI] [PubMed] [Google Scholar]
  53. Waxman K., Tremper K. K., Cullen B. F., Mason G. R. Perfluorocarbon infusion in bleeding patients refusing blood transfusions. Arch Surg. 1984 Jun;119(6):721–724. doi: 10.1001/archsurg.1984.01390180083014. [DOI] [PubMed] [Google Scholar]
  54. Woltjes J., de Jong J. C., ten Duis H. J., Wildevuur C. R. The priming of extracorporeal circuits: the effect on canine blood elements. Transfusion. 1979 Sep-Oct;19(5):552–557. doi: 10.1046/j.1537-2995.1979.19580059808.x. [DOI] [PubMed] [Google Scholar]
  55. Yokoyama K., Yamanouchi K., Watanabe M., Matsumoto T., Murashima R., Daimoto T., Hamano T., Okamoto H., Suyama T., Watanabe R. Preparation of perfluorodecalin emulsion, an approach to the red cells substitute. Fed Proc. 1975 May;34(6):1478–1483. [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES